Metabolic changes in cancer cells after metformin treatment
Abstract
Proliferation measured by confluency in Incucyte ZOOM. Viability by CCK8, Alamar Blue, and direct cell counting microscopically (metformin concentration range: 1.5-24 mM). Metabolic analysis usuaing the Seahorse XF96 (metformin exposure for 48 hours, 3 mM). GLUT1 expression measured via flow cytometry. Detailed methods found in published article.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.